We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Hospira Handed 483 for Releasing Non-Validated Carboplatin Injection
Hospira Handed 483 for Releasing Non-Validated Carboplatin Injection
January 3, 2012
Hospira, still struggling with GMP issues at its Rocky Mount, N.C., and Austin, Texas, facilities, has received a Form 483 for lacking documented validation processes at a Boulder, Colo., plant.